AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is scheduled to present at the JP Morgan 28th Annual Healthcare Conference on Monday, January 11. Representing the company will be its President and CEO Brian Pereira, MD. Dr. Pereira will provide a company update and discuss the company’s commercial launch of Feraheme®.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Dr. Pereira will begin his presentation at 11:00 am ET that morning. Interested parties may listen to his presentation via webcast on the company’s website, http://www.amagpharma.com/. The webcast will remain on the site for instant replay until February 11, 2010.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its technology for the development and commercialization of a therapeutic iron compound to treat anemia, and imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The Company has one product candidate, Feraheme (ferumoxytol injection), and two approved products, Feridex I.V. and GastroMARK. Feraheme is being developed for use as an intravenous (IV) iron replacement therapeutic agent for the treatment of iron deficiency anemia (IDA) and as a diagnostic agent for vascular enhanced magnetic resonance imaging (MRI) to assess peripheral arterial disease (PAD). Feridex I.V., the Company’s liver contrast agent, is approved and has been sold in the United States, Europe and other countries. In November 2008, ceased manufacturing Feridex I.V. GastroMARK, its oral contrast agent used for delineating the bowel in MRI, is approved and marketed in the United States, Europe, and other countries.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
